281 related articles for article (PubMed ID: 2457657)
1. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
Chiricuţă I; Ghilezan N
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
[No Abstract] [Full Text] [Related]
5. The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
Motzer RJ; Geller NL; Bosl GJ
Cancer; 1990 Sep; 66(5):857-61. PubMed ID: 1696846
[TBL] [Abstract][Full Text] [Related]
6. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
[TBL] [Abstract][Full Text] [Related]
7. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
Srougi M; Simon SD; de Góes GM
AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
[No Abstract] [Full Text] [Related]
8. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
[TBL] [Abstract][Full Text] [Related]
9. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
Williams SD; Birch R; Einhorn LH; Irwin L; Greco FA; Loehrer PJ
N Engl J Med; 1987 Jun; 316(23):1435-40. PubMed ID: 2437455
[TBL] [Abstract][Full Text] [Related]
10. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
[TBL] [Abstract][Full Text] [Related]
11. Effect of VAB-6 combination chemotherapy on malignant germ cell tumours in childhood.
Hayashi Y; Ohi R; Konno T; Tsuchiya S; Muraosa Y; Yaoita S; Watanabe T
Z Kinderchir; 1989 Aug; 44(4):208-12. PubMed ID: 2477963
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
Madej G; Gigier A; Siedlecki P; Pieńkowski T
Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
[No Abstract] [Full Text] [Related]
13. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
Tiuliandin SA
Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
[TBL] [Abstract][Full Text] [Related]
14. VAB-6 as initial treatment of patients with advanced seminoma.
Stanton GF; Bosl GJ; Whitmore WF; Herr H; Sogani P; Morse M; Golbey RB
J Clin Oncol; 1985 Mar; 3(3):336-9. PubMed ID: 2579214
[TBL] [Abstract][Full Text] [Related]
15. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
16. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
[TBL] [Abstract][Full Text] [Related]
17. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
19. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Brada M; Horwich A; Peckham MJ
Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
[TBL] [Abstract][Full Text] [Related]
20. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]